News
Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...
But now the FDA has rubber-stamped the approval of Luxturna, the first ever gene therapy it has backed, all the attention is now on Spark, and what price it plans to charge for the therapy.
Biogen has downbeat news about its gene therapy for the rare inherited eye disease, X-linked retinitis pigmentosa, announcing the shot failed to meet its target in a phase 2/3 study. A final FDA ...
If you've had to listen to your dad complain about his muscles aching after a workout, a massage gun is a lovely gift idea.
About the research: The report was based on data from an eye-tracking study conducted with 100 consumers who visit content sites regularly. Half of the participants were shown the desktop version of ...
It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore how race affects ...
Abstract: The effects of a drug on the genomic scale can be assessed in a three-color cDNA microarray with the three color ... applied to the hexaMplot can be used to detect groups of coexpressed ...
Shark Tank’s Barbara Corcoran didn’t hold back when sharing insight into her past cosmetic procedures, including three face lifts as well as eye lifts, fillers and more. Kris Jenner started ...
The global marijuana industry is projected to grow significantly through 2030. Top marijuana stocks to consider include Green Thumb Industries and Turning Point Brands. The investment risks with ...
College of Chemistry and Materials Science, Fujian Provincial Key Laboratory of Polymer Materials, Fujian Normal University, 32 Shangsan Road, Fuzhou 350007, China College of Chemistry and Materials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results